Furthermore, squalamine inhibits the growth of HER-2-negative breast cancer MCF-7 and HER-2-positive MCF-7 in combination with trastuzumab by blocking the action of the endogenous activator of angiogenesis VEGF [163]. Here, ERBB2 is linked to breast cancer.